Prudence N. Gatt
Westmead, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.
Journal: Frontiers in psychiatry
Published: July 14, 2025
Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia.
Journal: Pathology
Published: August 26, 2023
Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditions.
Journal: Genes and immunity
Published: January 19, 2021
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.
Journal: Data in brief
Published: December 26, 2016
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.
Journal: Journal of autoimmunity
Published: November 02, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Journal: The pharmacogenomics journal
Published: July 31, 2015
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 06, 2015
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 01, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Journal: Clinical immunology (Orlando, Fla.)
Published: December 02, 2013
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Journal: Human molecular genetics
Published: October 26, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 16, 2013
Last Updated: 09/26/2026